# Phase 3 rectal cancer trials recruiting: 32 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 32 trials in phase 3 for rectal cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 3 rectal cancer trials: 32 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-3/rectal-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 32
- Recruiting or not yet: 32
- Read on: November 19, 2026

## Trials

The 25 newest of 32, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 28, 2026 | NCT07900061 | Modified Short-Course Radiotherapy Combined With Tislelizumab and CAPOX for pMMR/MSS Rectal Cancer | Sir Run Run Shaw Hospital | Phase 3 | Not yet recruiting | Rectal Cancer | 210 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900061) |
| August 3, 2026 | NCT07740720 | A Study of the Duration of Dostarlimab in Untreated Mismatch Repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H) Locally... | GlaxoSmithKline | Phase 3 | Not yet recruiting | Neoplasms, Rectal | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07740720) |
| April 24, 2026 | NCT07549399 | SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC | Sixth Affiliated Hospital, Sun Yat-sen University | Phase 3 | Recruiting | Rectal Adenocarcinoma, High-Risk Cancer, MSS | 204 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07549399) |
| April 14, 2026 | NCT07528209 | Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer | Sun Yat-sen University | Phase 3 | Recruiting | Rectal Cancer, pMMR (Microsatellite Stable Rectal Cancer) | 556 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07528209) |
| January 28, 2026 | NCT07372300 | Modulated Electro-Hyperthermia in Combination With Multimodal Therapy for Locally Advanced Rectal Cancer | Sponsor not shown (see the record) | Phase 3 | Recruiting | Locally Advanced Rectal Carcinoma | 126 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07372300) |
| September 23, 2025 | NCT07188025 | ctDNA-Based Adjuvant Chemotherapy for High-Risk Rectal Cancer | Erasmus Medical Center | Phase 3 | Recruiting | Rectal Cancer | 103 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07188025) |
| August 20, 2025 | NCT07132463 | Neoadjuvant Chemoradiotherapy Followed by Chemotherapy With or Without Tislelizumab for Resectable Ultra-low Rectal Cancer: The RELIEVE-02... | Fudan University | Phase 3 | Recruiting | Rectal Cancer | 196 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07132463) |
| August 8, 2025 | NCT07113275 | A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy... | Sponsor not shown (see the record) | Phase 3 | Recruiting | Rectal Cancer, Total Neoadjuvant Therapy, Radiotherapy, Immunotherapy | 444 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07113275) |
| July 17, 2025 | NCT07070622 | Planed Organ Preservation for Low Rectal Cancer After Neoadjuvant Chemotherapy (OPLAR) | West China Hospital | Phase 3 | Recruiting | Rectal Cancer | 186 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07070622) |
| May 30, 2025 | NCT06997497 | A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012) | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Colon Adenocarcinoma, Rectal Adenocarcinoma | 477 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06997497) |
| May 13, 2025 | NCT06968221 | Bovine Reinforcement in Stomach, Colorectal and Lung Operation | Shanghai Cingularbio Co. Ltd | Phase 3 | Recruiting | Rectal Cancer Stage III, Lung Cancer Stage III | 172 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06968221) |
| April 20, 2025 | NCT06936774 | Improving Functional Outcomes and Quality of Life in Patients With Rectal Cancer After Surgery With Intensified Follow-up & Surveillance | University Hospital, Basel, Switzerland | Phase 3 | Recruiting | LARS - Low Anterior Resection Syndrome, Rectal Cancer Surgery, Rectal Cancer, Quality of Life (QOL) | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06936774) |
| February 27, 2025 | NCT06850090 | Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III Trial | Shandong Cancer Hospital and Institute | Phase 3 | Recruiting | Rectal Cancer, Rectal Cancer Patients | 210 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06850090) |
| February 18, 2025 | NCT06832917 | Short-course Radiation (SCRT) Followed by 6 Cycles of Cadonilimab Plus MFOLFOX6 As Neoadjuvant Therapy for Patients with Locally Advanced... | Sponsor not shown (see the record) | Phase 3 | Not yet recruiting | Rectal Cancer | 238 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06832917) |
| June 10, 2024 | NCT06450574 | Preoperative Chemoradiotherapy and Transanal Endoscopic Microsurgery Versus Ttransanal Endoscopic Microsurgery in T1 N0, M0 Rectal Cancer... | Corporacion Parc Tauli | Phase 3 | Not yet recruiting | Rectal Cancer Stage I | 106 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06450574) |
| January 29, 2024 | NCT06229041 | Total Neoadjuvant Treatment ±Immunotherapy for High Risk Locally Advanced Rectal Cancer (TNTi) | Peking University Cancer Hospital & Institute | Phase 3 | Recruiting | Rectal Cancer | 472 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06229041) |
| January 16, 2024 | NCT06205485 | Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer | Canadian Cancer Trials Group | Phase 3 | Recruiting | Rectal Cancer | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06205485) |
| November 8, 2023 | NCT06123156 | Interest of Early Erectile Rehabilitation With Sildenafil After Radiotherapy and Proctectomy for Rectal Cancer | University Hospital, Rouen | Phase 3 | Recruiting | Rectal Cancer | 188 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06123156) |
| October 24, 2023 | NCT06097416 | Neoadjuvant Chemoradiotherapy Versus Total Neoadjuvant Therapy in the Treatment of T3 Rectal Cancer | St. James's Hospital, Ireland | Phase 3 | Not yet recruiting | Rectal Cancer | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06097416) |
| August 9, 2023 | NCT05984485 | The Efficacy of Primary Total Mesorectal Excision (TME) Surgery Versus Neoadjuvant Chemotherapy Combined With TME Surgery in Low-risk... | Sun Yat-sen University | Phase 3 | Recruiting | Rectal Cancer | 766 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05984485) |
| July 11, 2023 | NCT05939687 | Prophylactic Mesh Placement During Stoma Closure After Low Anterior Resection | Blokhin's Russian Cancer Research Center | Phase 3 | Recruiting | Neoplasms Malignant, Rectal Cancer, Hernia Incisional, Surgery | 142 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05939687) |
| March 2, 2023 | NCT05752136 | Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma | Sir Run Run Shaw Hospital | Phase 3 | Recruiting | Rectal Cancer | 108 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05752136) |
| December 12, 2022 | NCT05646511 | TNT of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer | National Cancer Center Hospital East | Phase 3 | Recruiting | Locally Advanced Rectal Cancer | 608 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05646511) |
| January 21, 2022 | NCT05201430 | Neoadjuvant FOLFOXIRI Versus CapeOX Chemotherapy for Local Advanced Rectal Cancer | Fudan University | Phase 3 | Recruiting | Rectal Cancer | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05201430) |
| May 15, 2020 | NCT04389086 | Induction Chemotherapy for Locally Recurrent Rectal Cancer | Catharina Ziekenhuis Eindhoven | Phase 3 | Recruiting | Recurrent Rectal Cancer | 364 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04389086) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Sun Yat-sen University | 3 |
| Sir Run Run Shaw Hospital | 2 |
| National Cancer Center Hospital East | 2 |
| Fudan University | 2 |
| Sixth Affiliated Hospital, Sun Yat-sen University | 2 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 1 |
| University Hospital, Rouen | 1 |
| Corporacion Parc Tauli | 1 |
| Shandong Cancer Hospital and Institute | 1 |
| Vejle Hospital | 1 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 1 |
| West China Hospital | 1 |
| Blokhin's Russian Cancer Research Center | 1 |
| St. James's Hospital, Ireland | 1 |
| Catharina Ziekenhuis Eindhoven | 1 |
| University Hospital, Basel, Switzerland | 1 |
| Shanghai Cingularbio Co. Ltd | 1 |
| University of Aarhus | 1 |
| Erasmus Medical Center | 1 |
| Canadian Cancer Trials Group | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Peking University Cancer Hospital & Institute | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 14 |
| Japan | 4 |
| France | 3 |
| Netherlands | 3 |
| Canada | 2 |
| Taiwan | 2 |
| United States | 2 |
| Denmark | 2 |
| Argentina | 1 |
| Australia | 1 |
| Brazil | 1 |
| Chile | 1 |
| Colombia | 1 |
| Finland | 1 |
| Germany | 1 |
| Hong Kong | 1 |
| Hungary | 1 |
| Israel | 1 |
| Italy | 1 |
| Malaysia | 1 |
| Mexico | 1 |
| Philippines | 1 |
| Poland | 1 |
| Romania | 1 |
| Singapore | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Tax preparation firms in the United States](https://specstream.ai/data/businesses/tax-preparation-firms/united-states)
- [Cambodian restaurants in the United States](https://specstream.ai/data/businesses/cambodian-restaurants/united-states)
- [Honduran restaurants in the United States](https://specstream.ai/data/businesses/honduran-restaurants/united-states)
- [Prosthetics providers in the United States](https://specstream.ai/data/businesses/prosthetics-providers/united-states)
- [Armenian restaurants in the United States](https://specstream.ai/data/businesses/armenian-restaurants/united-states)
- [EMS training centers in the United States](https://specstream.ai/data/businesses/ems-training-centers/united-states)
